Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new release of the page metadata. No study content or user-facing features are indicated to be affected by this update.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site software/document rendering version rather than the clinical trial information.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded the term 'Small cell lung carcinoma' in the related terms and a link to the Genetic and Rare Diseases Information Center in the Resources section.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.